GRDN
Guardian Pharmacy Services, Inc.GRDN
GRDN
About: Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
105.31% more ownership
Funds ownership: 0% [Q2] → 105.31% (+105.31%) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$21
2%
downside
Avg. target
$23
5%
upside
High target
$24
12%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Truist Securities David Macdonald 56% 1-year accuracy 49 / 87 met price target | 12%upside $24 | Buy Maintained | 15 Nov 2024 |
Stephens & Co. Scott Fidel 51% 1-year accuracy 22 / 43 met price target | 2%downside $21 | Overweight Initiated | 22 Oct 2024 |
Financial journalist opinion
Neutral
Business Wire
4 days ago
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN) expands to New Jersey through partnership with long-term care pharmacy Freedom Pharmacy.
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Three Months Ended September 30, 2024 Revenue of $314.4 million, an increase of 20% year-over-year, driven by organic growth of the business and the previously announced acquisition of Heartland Pharmacy completed on April.
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Stephens Annual Investment Conference, being held in Nashville, on Thursday, November 21, 2024, including a fireside chat at 9:00am CT. The live audio webcast of the fireside chat will be available online at https://investors.guardianpharmacy.com. A replay of the fireside chat will also be availab.
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245.
Positive
Benzinga
2 months ago
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc GRDN, which operates long-term care pharmacies that facilitate the full lifecycle of pharmacy administration and associated consultative services for residents of long-term healthcare facilities (LTCFs).
Positive
Benzinga
2 months ago
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Positive
Seeking Alpha
2 months ago
U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up
Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Four IPOs and two SPACs submitted initial filings this past week. Six IPOs are currently scheduled to list in the week ahead.
Neutral
Reuters
2 months ago
Guardian Pharmacy shares rise 3% in lukewarm NYSE debut
Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million.
Positive
Reuters
2 months ago
Healthcare firm Guardian Pharmacy raises $112 mln in US IPO
Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday.
Neutral
Business Wire
2 months ago
Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the pricing of its upsized initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $14.00 per share. In addition, Guardian has granted the underwriters a 30-day option to purchase up to 1,200,000 additional shares of Class A common stock at the public offering price, less the underwriting discount. The shares are expected to begin trading on the New York Stock Exchan.
Charts implemented using Lightweight Charts™